Management of nausea and vomiting in patients with advanced cancer at the end of life
CPD Previous     Next

Management of nausea and vomiting in patients with advanced cancer at the end of life

Amanda Webb Macmillan clinical nurse specialist, Palliative care, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, England

The prevalence of nausea and vomiting in patients with advanced cancer varies, but it generally increases towards the end of life. Nausea and vomiting can be distressing and debilitating for patients, and can affect quality of life significantly. This article discusses the assessment of nausea and vomiting, current understanding of the emetic pathways, and pharmacological management of nausea and vomiting in patients with advanced cancer at the end of life.

Nursing Standard. 32, 10,53-63. doi: 10.7748/ns.2017.e10993

Correspondence

amanda.webb7@nhs.net

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Revalidation

Prepare for revalidation: read this CPD article, answer the questionnaire and write a reflective account: rcni.com/reflective-account

To write a CPD article

Please email tanya.fernandes@rcni.com. Guidelines on writing for publication are available at: rcni.com/writeforus

Received: 24 August 2017

Accepted: 19 September 2017